Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

The new delivery method for finasteride using nanoparticles may improve hair growth without skin issues.

Using a drug to activate bone marrow stem cells can help the liver regenerate and function better after major surgery in rats.

Researchers developed a quick and reliable method to test for betamethasone dipropionate and calcipotriol in ointments and drugs.

Low-dose oral minoxidil can be effective for hair loss but should be avoided in people with certain heart conditions and severe liver problems.

Minoxidil works better when applied on a damp scalp than a dry one.

Finasteride, a drug that prevents testosterone conversion, can effectively reduce blood loss in prostate surgery, especially for patients with a prostatic volume over 30 cc, and decrease post-surgery complications.

Dutasteride reduces DHT more than finasteride, but both drugs improve BPH symptoms similarly.

A reliable method was developed to measure gemcitabine and olaparib in pancreatic tissue, aiding pancreatic cancer treatment.

Valproate sustained-release is effective and generally safe for short-term treatment of new partial epilepsy.

Particle properties affect drug retention and release in minoxidil foams, with lipid nanoparticles having higher loading capacity.

Nanoparticles improve drug delivery through the skin but more research is needed on their long-term effects and skin penetration challenges.

Niosomes are a promising and effective way to deliver drugs through the skin.

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.

Older men with severe symptoms and larger prostates should focus on prevention, using finasteride and alpha-blockers to manage acute urinary retention.

Minoxidil and caffeine in transfersomes improve hair growth treatment.

The flutamide-loaded hydrogel is a promising, skin-friendly treatment for acne and hair loss, potentially requiring less frequent application.

Scientists developed a new method to deliver alopecia treatment directly to hair follicles, which could be a promising treatment for hair loss and other hair diseases.

Treatments for acute leukaemia lead to high remission rates, but relapses occur, requiring ongoing advancements in care.

Nanoparticles with more oleic acid improved the delivery and stability of the drug spironolactone.

Smart hydrogel dressings could improve diabetic wound healing by adjusting to wound conditions and controlling drug release.

Low-dose oral minoxidil effectively treats alopecia but can cause side effects like excess hair growth and fluid retention.

Improved tablets lead to faster, better drug absorption for hair loss treatment.

Cubosomes improve drug delivery for skin and eye diseases by enhancing adhesion, retention, and release.

Ethosomes improve drug delivery through the skin but may have side effects like irritation.

Adding Brij 78 to minoxidil microparticles in a certain solution helps them stick to the skin better and prevents clumping.

Using existing drugs for new treatments is cost-effective and safer.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Low-level laser therapy reduces orthodontic relapse in rats, but fulvic acids do not.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.